Meeting
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccination behavior and outcomes in patients with genitourinary cancer in comparison with other cancer types.
Authors
Hyma Vani Polimera
Penn State Cancer Institute, Hershey, PA
Hyma Vani Polimera , Lauren Danielle Pomerantz , Emma Guare , Junjia Zhu , Monika Joshi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Clinical Trial Registration Number
NCT04953065
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 134)
DOI
10.1200/JCO.2023.41.6_suppl.134
Abstract #
134
Poster Bd #
E14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny
Poster
2022 ASCO Genitourinary Cancers Symposium
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies.
First Author: Zeynep Busra Zengin
Poster
2024 ASCO Quality Care Symposium
Implementation of Covid-19 assessment in 5 rural oncology clinics and resulting impact on immunization culture.
First Author: Issam Makhoul
Poster
2024 ASCO Quality Care Symposium
Impact of respiratory syncytial virus infection among patients with hematological cancer in the era of post-coronavirus pandemic.
First Author: Gin-Yi Lee